Médecins Sans Frontières has launched a tool kit for costing clinical research and is urging others to use it to increase transparency

The first EU-funded research project into psychedelic drugs is a step on the way to legitimise the field and should lead to more funding

MEPs voted to adopt their negotiating position on the controversial reform, but it will not be finalised until after the European elections in June. Despite concessions, the pharma industry is not happy

After long negotiations MEPs agreed on the EU’s pharmaceutical reform. It includes longer exclusivity for data filed to get marketing approval for new drugs. But pharma still isn’t happy

Clinical research backed by the EU is bringing life-saving medicines and health tools to sub-Saharan Africa. This success story offers a valuable lesson as negotiations get underway on the next research programme

It is promised as the most important update for more than twenty years, but tensions are high as MEPs struggle to reach a compromise over the EU’s proposed pharmaceutical reform

Research commissioned by lobby group EFPIA shows Germany, Belgium and France will be among those hit hardest if the Commission’s proposals go ahead. In total, R&D would be cut by €2B per annum